Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by Trader8on Mar 18, 2018 12:22pm

245 Views

Post# 27735750

RE:RE:RE:If

SpaceBeer wrote:

Trader8 wrote:

Scoopnewf wrote: No halt first thing at the bell, stock will move up guessing 25%_30%, then if no news for the rest of the day the stock will be shorted hard to the down side guessing -30 for a days end. Better to see them shorting than the SP go to $2. JMOO GLTA

What a stupid comment, why is it better for it to be shorted?

I think there is a "then" for "than" typo in Scoop's post meaning that the shorters would lose a ton of money on the upswing to 2$. GLTA

Ahhh....Ok, I withdraw my 'What a stupid comment'....comment.

Bullboard Posts

A junior copper-gold stock trading at a bargain of monumental proportions